ClinicalTrials.gg
RecruitingNCT05943743Updated Jan 7, 2025

Hiccups and Obstacles Of E-Learning Among Medical Sudents

An observational study in Covid-19, E-learning and Medical Student, sponsored by Bahria University. Recruiting at 1 site in Pakistan. Open to participants aged 18 Years to 25 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-01-07.

Sponsored by Bahria University · Observational

How we know

From the registry’s dates

  • Primary completion was expected by Mar 2025, 1 year 7 months ago, but the record still lists the study as recruiting.
  • Started Dec 2022; still recruiting 3 years 11 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Other
Time perspective
Cross-sectional
Enrollment
600
Ages
18 Years to 25 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 98 studies in COVID-19 with a site in Pakistan — 3 open to participants now, 4 under way, 2 of them phase 3. COVID-19 · Pakistan.

Planned enrollment
12th of 27
600 · median 373
Started
2022
with 12 others
Observational
27 of 98
1 open now
Registered
96th of 98
by date

Among the 98 studies in COVID-19 with a site in Pakistan, this one is the 12th largest by planned enrollment of the 27 observational ones that give a count, is one of 13 that started in 2022, is one of 27 observational ones, and was the 96th registered.

COVID-19

7,996 studies on the registry are indexed under COVID-19; 469 are open to participants now.

Browse COVID-19 studies →

Open to participants now

3 of the 98 studies in COVID-19 with a site in Pakistan are open now. Recruiting first, the newest first:

All 3 open studies →

A study can be open while its sites in Pakistan have not opened yet or have stopped. Only those recruiting at a site in Pakistan →

Who these studies take

Of the 356 COVID-19 studies recruiting now, 205 (58%) set no upper age limit and 84 (24%) stop at 75 or younger; 90 take children under 18; 135 take healthy volunteers.

This study: 18 Years to 25 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 98 studies in COVID-19 with a site in Pakistan, or all of them as a file.
02

Study summary

The COVID-19 Pandemic is the characterizing worldwide wellbeing emergency within recent memory. Since its development in Asia before the end of last year, the infection has spread to each mainland with the exception of Antarctica. Countries are dashing to moderate the spread of the illness by testing and treating patients, completing contact following, restricting travel, isolating residents, and dropping huge social occasions like games, shows, and educational institutes.

As almost every institution was closed for the safety of human kind. All educational institutes were also closed for any kind of education. Also, In Pakistan all educational institutes were closed since march 2020. It was impossible to keep educational activities closed for long. In order to keep educational activities in working e-learning was introduced through out the world. As many other countries Pakistan also started e-learning for all students.

Read the detailed description

A world is transitioning from physical classes to hybrid studies. Pakistan is listed among third world country the availability of infra structure for hybrid study is not well developed, as consequence many hurdles and barriers are being faced by students, this has also been seen during covid-19 too. Distance E-learning in medical education may represent a suitable alternative to traditional learning to deliver high-quality education. The availability of essential infrastructures and efficient institutional strategies represent a major challenge for integrating distance learning in medical education.

During the pandemic, instructors and teaching staff were required to adapt quickly to the rapid transition in the education process and depend completely on the online platforms available, to deliver their courses, exams, and other required teaching and learning activities. While rapid transition to distance online learning was a mandatory and necessary action to ensure the learning continuity during the COVID-19 pandemic, it was not always a smooth process, that posed many challenges for instructors, learners.

Distance E-Learning is defined as using technology to deliver training, including technology supported learning either online, offline, or both. It is aimed at the effective construction of knowledge regarding individual experience, practice, and knowledge of the learners and students. Internet-based learning, computer-based learning, virtual classrooms, and digital collaboration all represent different types of e-learning

03

Conditions studied

  • Covid-19
  • E-learning
  • Medical Student

Browse trials for

Keywords

  • Covid-19
  • obstacles
  • Screen Time
04

Who can participate

Ages eligible
18 Years to 25 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Undergraduate students of both private and government sector of medical institutes.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

All undergraduate medical students of Pakistan.

Exclusion criteria

Exclusion Criteria:

Postgraduate Medical students Teaching Faculty

05

Study design

Observational model
Other
Time perspective
Cross-sectional
Enrollment
600 participants (estimated)
Patient registry
No

Interventions

  • OtherGoogle form

    * Self-administrated Questionnaire will be used for online survey. A pilot study was conducted on 30 sample size to check the reliability of questionnaire via statistical test. * A Five-point Likert scale (strongly disagree, disagree somewhat, Neutral, agree somewhat, strongly agree)

06

What researchers measure

Primary outcomes

  1. Difference of students educational level will assessed using Likert scale

    During lockdown due to covid-19 medical students studies effected drastically. Academic level will be measured through likert scale in which 1 means good, 2 means average and 3 means below average. Academic level will be compared on the basis of students reply before and during covid academic result.

    Time frame: 30 days

Secondary outcomes

  1. Majority of students are facing internet and accessibility problems during online classes

    students problem during online classes assessed using likert scale in which 1 means minimum issues facing and 5 means maximum issues facing during online classes

    Time frame: 30 days

Other outcomes

  1. Level of interest among students were very low due to online classes

    Interest level towards studies was low may be due to technical issues. these parameters will be assessed through Likert Scale, in which 1 means strongly agree, 2 means agree, 3 means neutral, 4 mean disagree and 5 means strongly disagree

    Time frame: 30 days

07

Study locations

1 of 1 sites recruiting
  • BUMDC
    Karachi, Sindh 75500, Pakistan
    Recruiting
08

References and documents

Individual participant data

Plan to share: Yes — Data collection procedure, results and limitation and strengths will be shared through publication.

Supporting information: Study protocol, Statistical analysis plan, Informed consent form

Time frame: By the end of year 2023

Access criteria: Publications

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Dec 2022 (actual). Primary completion is estimated for Mar 2025, 27 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 16, 2023
First posted
Jul 13, 2023
StartActual
Dec 20, 2022
Primary completionEst.
Mar 30, 2025
CompletionEst.
Dec 15, 2025
Last update
Jan 7, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 7, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05943743
Lead sponsor
Bahria University
Responsible party
Rabia Khan (Assistant Professor, Bahria University) — Principal investigator
First posted
Jul 13, 2023
Start date
Dec 20, 2022
Primary completion
Mar 30, 2025 (estimated)
Completion
Dec 15, 2025 (estimated)
Last update
Jan 7, 2025

Study contacts

Rabia Khan, Msc(PT)
Contact
iamrabiakhan@gmail.com
+923452310047
Muhammad Usman, PPDPT
Contact
usman.bumdc@gmail.com
+923333172771
Rabia Khan, Msc(PT)
principal investigator · Bahria University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion